Cargando…
Growing risk of aristolochic acid nephropathy in the era of COVID-19 – Correspondence
Autores principales: | Das, Tuyelee, Mukerjee, Nobendu, Ghosh, Arabinda, Lorenzo, Jose M., Dhama, Kuldeep, Dey, Abhijit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IJS Publishing Group Ltd. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650990/ https://www.ncbi.nlm.nih.gov/pubmed/36372186 http://dx.doi.org/10.1016/j.ijsu.2022.106992 |
Ejemplares similares
-
Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023) -
Omicron with threatened antagonistic consequences and are convoyed by new fangled risks – Correspondence
por: Mukerjee, Nobendu, et al.
Publicado: (2022) -
Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018) -
Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023) -
Autophagy and Alzheimer’s disease: How far science has to be progressed? − correspondence
por: Emran, Talha B., et al.
Publicado: (2023)